At a glance
ClinicalIndex Comparison RecordN/ACompleted· 4,430 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Highly Effective Reversible Contraceptive Initiative-Salt Lake (HER-SL)
In Brief
An observational study for Birth Control and Contraception. Completed, enrolled 4,430 participants across 1 site.
Detailed Summary
This study aims to understand the long-term health, social, and economic impacts of transitioning a community to Highly Effective Reversible Contraception (HER-C).
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBirth Control, Contraception
CountriesUnited States
Timeline
N/ACompletedFinished
201520162017201820192020202120222023202420252026
Enrollment StartNov 2014
First PostedApr 2016
Primary CompletionMar 2020
TodayJul 2026
First PostedApr 12, 2016
Enrollment StartNov 1, 2014
Primary CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 5.3 yearsPosted 10.2 years ago